SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7656624
Source:
http://linkedlifedata.com/resource/pubmed/id/7656624
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013404
,
umls-concept:C0015259
,
umls-concept:C0024117
,
umls-concept:C0242896
,
umls-concept:C0449295
,
umls-concept:C0758515
,
umls-concept:C1272745
,
umls-concept:C1282910
pubmed:issue
3
pubmed:dateCreated
1995-10-5
pubmed:abstractText
To evaluate the impact of a week-long course of inhaled albuterol compared with ipratropium on expiratory peak flow, exercise performance, and dyspnea in patients with stable COPD.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7656624-8769538
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0231335
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-2 Receptor Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinergic Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Ipratropium
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0012-3692
pubmed:author
pubmed-author:BlosserS ASA
,
pubmed-author:LocalioA RAR
,
pubmed-author:MaxwellS LSL
,
pubmed-author:Reeves-HocheM KMK
,
pubmed-author:ZwillichC WCW
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
730-5
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:7656624-Administration, Inhalation
,
pubmed-meshheading:7656624-Adrenergic beta-2 Receptor Agonists
,
pubmed-meshheading:7656624-Adrenergic beta-Agonists
,
pubmed-meshheading:7656624-Aged
,
pubmed-meshheading:7656624-Albuterol
,
pubmed-meshheading:7656624-Cholinergic Antagonists
,
pubmed-meshheading:7656624-Cross-Over Studies
,
pubmed-meshheading:7656624-Double-Blind Method
,
pubmed-meshheading:7656624-Dyspnea
,
pubmed-meshheading:7656624-Exercise Tolerance
,
pubmed-meshheading:7656624-Female
,
pubmed-meshheading:7656624-Forced Expiratory Volume
,
pubmed-meshheading:7656624-Humans
,
pubmed-meshheading:7656624-Ipratropium
,
pubmed-meshheading:7656624-Lung Diseases, Obstructive
,
pubmed-meshheading:7656624-Male
,
pubmed-meshheading:7656624-Multivariate Analysis
pubmed:year
1995
pubmed:articleTitle
Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
pubmed:affiliation
Division of Pulmonary/Critical Care Medicine, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't